Ovid Therapeutics (OVID) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

OVID is expected to report earnings to fall 274.75% to -20 cents per share on November 07

Ovid Therapeutics OVID Stock Earnings Reports

Q3'24

Est.

$-0.21

Q2'24

Beat

by $0.34

Q1'24

Beat

by $0.05

Q4'23

Est.

$-0.22

Q3'23

Beat

by $0.03

The last earnings report on August 13 showed earnings per share of 11 cents, beating the estimate of -22 cents. With 103.30K shares outstanding, the current market capitalization sits at 83.75M.

View a ticker or compare two or three

Compare

OVID

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For OVID
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Provides medicines to children and adults with neurological disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

441 Ninth Avenue

Phone

+1 646 661-7661

Employees

Web

https://www.ovidrx.com